1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterization and management of adverse reactions (ARs) in patients with advanced renal cell carcinoma (aRCC) receiving lenvatinib plus pembrolizumab (CLEAR study)
    Meeting Abstract

    Motzer, R.; George, S.; Merchan, J. R.; Hutson, T. E.; Song, X.; Perini, R. F.; Xie, R.; Bapat, U.; Ebaid, B.; Puente, J.
    Asia-Pacific Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours
    Meeting Abstract

    Zebic, D.; Stockler, M.; Martin, A.; Pashankar, F.; Tran, B.; Mazhar, D.; Huddart, R.; Wheater, M.; Walpole, E.; Dunwoodie, E.; more...
    Asia-Pacific Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • The updated SIOG COVID-19 working group recommendations on COVID-19 vaccination among older adults with cancer
    Meeting Abstract

    Mislang, A.; Soto-Perez-De-Celis, E.; Hernández-Favela, C. G.; Russo, C.; Colloca, G.; Williams, G. R.; O'Hanlon, S.; Cooper, L.; O'Donovan, A.; Audisio, R.; more...
    Asia-Pacific Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Primary analysis of phase 2 results for cemiplimab in patients with mBCC who progressed on or were intolerant to hedgehog inhibitors
    Meeting Abstract

    Lewis, K. D.; Peris, K.; Sekulic, A.; Stratigos, A. J.; Dunn, L.; Eroglu, Z.; Chang, A. L. S.; Migden, M. R.; Yoo, S. K.; Mohan, K.; more...
    Journal of Oncology Navigation & Survivorship (2022)

    Fulltext@MSK | Save
  • Intracranial activity of tepotinib in patients with MET Exon 14 (METex14) skipping non-small-cell lung cancer (NSCLC) enrolled in VISION
    Meeting Abstract

    Hill, R.; Leighl, N.; Bestvina, C.; Patel, J.; Le, X.; Veillon, R.; Anderson, I.; Demedts, I.; Garassino, M. C.; Mazières, J.; more...
    Journal of Oncology Navigation & Survivorship (2022)

    Fulltext@MSK | Save
  • Industry payments to physicians are kickbacks. How should stakeholders respond?
    Journal Article

    Mitchell, A.; Sarpatwari, A.; Bach, P. B.
    Journal of Health Politics, Policy & Law (2022)

    Fulltext@MSK | Save
  • Subacute abdominal pain in a patient with chronic liver disease and hepatocellular carcinoma
    Miscellaneous

    Zheng-Lin, B.; Faleck, D. M.; Harding, J. J.
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Prophylactic radiation therapy vs. standard-of-care for patients with high-risk, asymptomatic bone metastases: A multicenter, randomized phase II trial
    Meeting Abstract

    Gillespie, E. F.; Mathis, N. J.; Marine, C.; Zhang, Z.; Barker, C. A.; Guttmann, D. M.; Kotecha, R.; McIntosh, A. F.; Vaynrub, M.; Bartelstein, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Matching adjusted indirect comparison of PFS & OS comparing ribociclib + letrozole vs palbociclib + letrozole as first-line treatment of HR+/HER2− ABC: Analysis based on updated PFS & final OS results of MONALEESA-2 & PALOMA-2
    Meeting Abstract

    Jhaveri, K.; O'Shaughnessy, J.; Fasching, P.; Cardoso, F.; Tolaney, S.; Hamilton, E.; Sharma, V. K.; Biswas, C.; Haftchenary, S.; Pathak, P.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save